(Q30368543)

21 June 2017

title

Long-term drug prevention trials. (English)

1 reference

21 June 2017

1 reference

Curtis L Meinert

1

1 reference

21 June 2017

publication date

1 January 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

5

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

168-176

1 reference

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Eulogy for a quality measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Surrogate endpoints in clinical trials: cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Large-scale randomized evidence: large, simple trials and overviews of trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Familial patterns of risk in very late-onset Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

The limitations of "vulnerability" as a protection for human research participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Predictors of attendance and dropout at the Lung Health Study 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Stopping the active intervention: CARET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508089458

21 January 2018

Identifiers

DOI

10.1177/1740774508089458

1 reference

21 June 2017

1 reference